Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Conditions

• Peripheral T Cell Lymphoma

Interventions

• OTHER: allogeneic peripheral blood stem cell transplantation

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine